BDBM575595 N,N'-(2,2'-dimethyl-[1,1'- biphenyl]-3,3'-diyl)bis(5-((2- oxa-6-azaspiro[3.3]heptan-6-yl) methyl)-4-methoxypicolinamide)::US11459339, Example 58

SMILES COc1cc(ncc1CN1CC2(COC2)C1)C(=O)Nc1cccc(c1C)-c1cccc(NC(=O)c2cc(OC)c(CN3CC4(COC4)C3)cn2)c1C

InChI Key InChIKey=OBPLGCQFKVAGJW-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 575595   

TargetProgrammed cell death 1 ligand/protein 1(Human)
Abbisko Therapeutics

US Patent
LigandPNGBDBM575595(US11459339, Example 58 | N,N'-(2,2'-dimethyl-[1,1'...)
Affinity DataIC50: 0.220nMAssay Description:The effect of compounds and positive compounds of the examples of the present invention on the interaction between PD-1 and PD-L1 was determined by t...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/7/2022
Entry Details
US Patent